Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
and completely reduces radiation-induced AKT phosphorylation below the level of control
GSK2110183B
a with a Kd of 0
CAS Number: 844499-71-4
and c-Met-T1010I with IC50 of 3
DCC-2036 t N-oxide and completely reduces radiation-induced AKTDCC 2036, is an orally bioavailable small molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor DCC 2036 binds to and inhibits the Bcr Abl fusion oncoprotein by changing the conformation of the folded protein to disallow ligand dependent and ligand independent activation; in addition, this agent binds to and inhibits Src family kinases LYN, HCK and FGR and the receptor tyrosine
US$ 337.00
US$ 1175.00